Transparency Market Research (TMR) () has published a new report titled, ‘Endocrine Testing Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2027’. According to the report, the global endocrine testing market was valued at US$ 5.5 Bn in 2018 and is projected to expand at a CAGR of 6.4% from 2019 to 2027.
Read Report Overview - https://www.transparencymarketresearch.com/endocrine-testing-market.html
Overview
- Endocrine system is made up of endocrine glands that secrete hormones directly into the blood stream. Tests are performed to monitor levels of endocrine hormones (such as follicle stimulating hormone (FSH), Luteinizing Hormone (LH), estradiol, insulin and others) from biological samples. These tests aid in detection of deviation in the hormone production i.e. they help detect either hypersecretion (excess secretion) or hyposecretion (less secretion) that results in certain endocrine disorders such as infertility, menopause, thyroid dysfunction and others.
- The Endocrine Testing market is currently booming one, owing to consistent rise in diabetic and obese population resulting in development of several health disorders thereby enhancing the growth and acceptance of endocrine test kits and methodologies. Moreover endocrine test kit manufacturers are focusing on the development of efficient diagnostic test kits of high accuracy which are the factors anticipated to drive the growth of market.
- North America dominates the global endocrine testing market in 2018 and the trend is anticipated to continue during the forecast period. The growth of market in the region is attributed to increasing obesity and changing lifestyle and less physical inactivity resulting in several endocrine disorders., Also, increasing incidences of diabetes worldwide followed by constant technological upgradation in testing further propel the growth and adoption of endocrine testing platforms.
- Asia Pacific is likely to be a highly lucrative market for the Endocrine Testing market and it is expected to expand at a high CAGR during the forecast period. Vast patient pool, increasing healthcare expenditure and demand for newer advanced therapies are key factors likely to boost endocrine testing market in Asia Pacific.
Request Brochure –
https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1645
Rise in Prevalence of Endocrine and Metabolic Disorders to Drive Global Endocrine Testing Market
- Disorders such as hypothyroidism, hyperthyroidism, diabetes mellitus, polycystic ovary syndrome (PCOS) among others are the most common endocrine & metabolic disorders among the global population. Thus, surge in number of people of above-mentioned conditions is anticipated to drive the growth of market.
Thyroid Stimulating Hormone (TSH) Test Segment to Dominate Endocrine Testing Market
- In terms of type, the global endocrine testing market has been segmented into Estradiol (E2) Test, Follicle Stimulating Hormone (FSH) Test, Human Chorionic Gonadotropin (hCG) Test, Luteinizing Hormone (LH) Test, Dehydroepiandrosterone sulfate (DHEAS) Test, Progesterone Test, Testosterone Test, Thyroid Stimulating Hormone (TSH) Test, Prolactin Test, Cortisol Test, Insulin Test and Others (Gastrin, Thymosin, Secretin, etc.). Demand for Thyroid Stimulating Hormone (TSH) Test is anticipated to rise during the forecast period, as Thyroid disease is the most common in the general population, with its prevalence increasing with age and laboratory measurement of serum TSH is an essential tool for diagnosing and managing various thyroid disorders, This in turn would drive the growth of segment.
Request COVID Analysis on Endocrine Testing Market – https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=1645
Clinical Chemistry Technology segment to dominate the Endocrine Testing Market
- In terms of technology, the global endocrine testing market has been segmented into Tandem Mass Spectrometry, Immunoassay technologies, Monoclonal and Polyclonal Antibody Technologies, Sensor Technologies, Clinical Chemistry Technologies and Others. Demand for Tandem Mass Spectrometry is anticipated to rise majorly due to the growing use of tandem mass spectrometry in combination with chromatography technique to overcome the challenges connected with old traditional techniques used for endocrine testing. Sensor technology is expected to be the fastest growing technology during the forecast period due to the rise in use of biosensors for diagnosis at home.
Commercial Laboratories Segment to be the Fastest Growing in the Endocrine Testing Market
- In terms of End User, the global endocrine testing market has been segmented into Hospitals, Commercial Laboratories, Ambulatory Care Centers, Home Based tests and Physician Offices. The commercial laboratories is the anticipated to be the fastest growing segment due to the availability of technologically advanced products for the rapid test results contributing to the growth of the segment.
Request Customization on Endocrine Testing Market Report – https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=1645
North America to Dominate Global Endocrine Testing Market
- In terms of region, the global Endocrine Testing market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominated the global Endocrine Testing market in2018, followed by Europe.
- North America accounted for major share of the global Endocrine Testing market in High disease prevalence, supportive healthcare and payer infrastructure, and hub for key industry players are the major drivers of the endocrine testing market in the region.
- The Endocrine Testing market in Asia Pacific is anticipated to expand at a high CAGR from 2019to Unmet medical needs, untapped nature of the market, increase in awareness about diseases such as PCOS, Thyroid disorders and improving health care infrastructure are the key factors for endocrine testing market growth in the region
Competitive Landscape
- The global endocrine testing market is fragmented in terms of number of players. Key players in the global Endocrine Testing market include Agilent Technologies, F-Hoffmann La Roche Ltd., AB SCIEX, and Thermo Fisher Scientific, Abbott Laboratories, Bio-Rad Laboratories, DiaSorin S.p.A, Beckman Coulter Inc, Siemens Healthineers and bioMerieux
Global Endocrine Testing Market is expected to reach USD 13.02 billion by 2024.
With the help of network of glands, hormones are produced, stored, and secreted.
Thymus, adrenal glands, testes, hypothalamus, pituitary gland, ovaries, pineal gland, islet cells in the pancreas, thyroid, and parathyroid are glands of endocrine system.
Insulin, estradiol (E2), cortisol, Follicle Stimulating (FSH), prolactin, Human Chorionic Gonadotropin (hCG), Thyroid Stimulating Hormone (TSH), Luteinizing Hormone (LH), testosterone, Dehydroepiandrosterone sulfate (DHEAS), progesterone, and other test type could be explored in endocrine testing market in the forecast period.
Thyroid Stimulating Hormone (TSH) sector accounted for the largest market share of endocrine testing industry and is estimated to lead the overall market in the coming years.
Moreover, insulin test is estimated to grow at fastest pace in the coming years, as growing diabetic population.
A novel research report on Global Endocrine Testing Systems Market has been recently published by Reports and Data covering latest trends and key market developments during the forecast period from 2018 to 2026.
The report offers an in-depth analysis of forecast insights, market size, emerging trends, revenue growth, top companies, growth factors, restraints and opportunities in the global Endocrine Testing Systems market.
The report also offers an accurate analysis of competitive landscape, sales statistics and regional manufactures.
The data has been extracted through extensive research and is further validated by professionals and experts in the industry.
The report uses charts, graphs, tables and figures to visually reflect the statistical data collected and makes it easier for readers to understand the market situation.
The report also provides insights of the top key companies operating the market.Request Free Sample: https://www.reportsanddata.com/sample-enquiry-form/2240 Increasing incidence of diabetes, sedentary lifestyle, growing healthcare awareness, increasing government support & obesity are some of the key factors projected to surge the demand for Endocrine testing, thereby propelling the market growth.
Transparency Market Research (TMR) () has published a new report titled, ‘Endocrine Testing Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2027’.
According to the report, the global endocrine testing market was valued at US$ 5.5 Bn in 2018 and is projected to expand at a CAGR of 6.4% from 2019 to 2027.Read Report Overview - https://www.transparencymarketresearch.com/endocrine-testing-market.html OverviewEndocrine system is made up of endocrine glands that secrete hormones directly into the blood stream.
they help detect either hypersecretion (excess secretion) or hyposecretion (less secretion) that results in certain endocrine disorders such as infertility, menopause, thyroid dysfunction and others.The Endocrine Testing market is currently booming one, owing to consistent rise in diabetic and obese population resulting in development of several health disorders thereby enhancing the growth and acceptance of endocrine test kits and methodologies.
Moreover endocrine test kit manufacturers are focusing on the development of efficient diagnostic test kits of high accuracy which are the factors anticipated to drive the growth of market.North America dominates the global endocrine testing market in 2018 and the trend is anticipated to continue during the forecast period.
The growth of market in the region is attributed to increasing obesity and changing lifestyle and less physical inactivity resulting in several endocrine disorders., Also, increasing incidences of diabetes worldwide followed by constant technological upgradation in testing further propel the growth and adoption of endocrine testing platforms.Asia Pacific is likely to be a highly lucrative market for the Endocrine Testing market and it is expected to expand at a high CAGR during the forecast period.
Vast patient pool, increasing healthcare expenditure and demand for newer advanced therapies are key factors likely to boost endocrine testing market in Asia Pacific.Request Brochure – https://www.transparencymarketresearch.com/sample/sample.php?flag=B_id=1645Rise in Prevalence of Endocrine and Metabolic Disorders to Drive Global Endocrine Testing MarketDisorders such as hypothyroidism, hyperthyroidism, diabetes mellitus, polycystic ovary syndrome (PCOS) among others are the most common endocrine & metabolic disorders among the global population.
Endocrine Testing Market is expected to reach USD 13.02 billion by 2024.
With the help of network of glands, hormones are produced, stored, and secreted.
Request a Sample PDF Copy of This Report @ https://www.millioninsights.com/industry-reports/endocrine-testing-market/request-sample The key driving factors responsible for the growth of Endocrine Testing market : Thymus, adrenal glands, testes, hypothalamus, pituitary gland, ovaries, pineal gland, islet cells in the pancreas, thyroid, and parathyroid are glands of endocrine system.
The endocrine testing market is estimated to grow at a significant CAGR of 8.0% over the future period as the scope and its applications are rising enormously across the globe.
Insulin, estradiol (E2), cortisol, Follicle Stimulating (FSH), prolactin, Human Chorionic Gonadotropin (hCG), Thyroid Stimulating Hormone (TSH), Luteinizing Hormone (LH), testosterone, Dehydroepiandrosterone sulfate (DHEAS), progesterone, and other test type could be explored in endocrine testing market in the forecast period.
Thyroid Stimulating Hormone (TSH) sector accounted for the largest market share of endocrine testing industry and is estimated to lead the overall market in the coming years.
